{
  "first_published_at": "2014-03-12", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON392872", 
  "title": "Dorzolamide hydrochloride/timolol maleate (Cosopt) preservative-free eye drops: new pipette design", 
  "tags": "{\"parsed_therapeutic\": [\"ophthalmology\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Ophthalmology\"]}", 
  "_document_number": 32, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/dose_icon.png", 
  "therapeutic_area": [
    "ophthalmology"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Dorzolamide hydrochloride/timolol maleate (Cosopt) preservative-free eye drops: new pipette design</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: March 2014</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--<br />\nA new pipette design was introduced in February 2014 as an interim measure. The instructions for using the new design are enclosed in the product packaging. The old pipette design is now being withdrawn.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>In December 2013 we <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON350696\">reported eye injuries</a> caused by the pipette design of Cosopt preservative-free eye drops. Because of these injuries, a new pipette design was introduced in February 2014 as an interim measure. The instructions for using the new design are enclosed in the product packaging. The old pipette design is now being withdrawn. Please see <a target=\"_blank\" href=\"/home/groups/comms-po/documents/news/con370021.pdf\">further guidance on the MHRA website</a>, including an updated Patient Information Leaflet and detailed instructions for use.</p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>In December 2013 we <a target=\"_blank\" href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON350696\">reported eye injuries</a> caused by the pipette design of Cosopt preservative-free eye drops. Because of these injuries, a new pipette design was introduced in February 2014 as an interim measure. The instructions for using the new design are enclosed in the product packaging. The old pipette design is now being withdrawn. Please see <a target=\"_blank\" href=\"http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con370021.pdf\">further guidance on the MHRA website</a>, including an updated Patient Information Leaflet and detailed instructions for use.</p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2014-03-01", 
  "date_last_modified": "2014-03-13", 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "further guidance on the MHRA website", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con370021.pdf", 
      "filename": "downloads/462b7ac602f73d6d42166ab106ba95eba2343bab/con370021.pdf", 
      "original_filename": "con370021.pdf"
    }
  ], 
  "_item_id": 32, 
  "summary": "", 
  "body": "Article date: March 2014\n\nIn December 2013 we [reported eye injuries](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON350696) caused by the pipette design of Cosopt preservative-free eye drops. Because of these injuries, a new pipette design was introduced in February 2014 as an interim measure. The instructions for using the new design are enclosed in the product packaging. The old pipette design is now being withdrawn. Please see [ASSET_TAG](#ASSET0), including an updated Patient Information Leaflet and detailed instructions for use.\n"
}